New study tests Mix-and-Match COVID boosters for african teens and adults
NCT ID NCT07408297
First seen Feb 15, 2026 · Last updated Apr 29, 2026 · Updated 8 times
Summary
This study tested the safety and immune response of different COVID-19 booster vaccines (Janssen, Moderna, Pfizer, or Novavax) in about 1,900 people aged 12 to 64 in Kenya, Democratic Republic of Congo, and Rwanda. It included both people with and without HIV to see how well the vaccines work in these groups. The goal was to find safe and effective booster options that can be used flexibly in areas with limited vaccine supply.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Victoria Biomedical Research Institute
Kisumu, Kenya
Conditions
Explore the condition pages connected to this study.